Menu
Enrolling by invitation NCT00186147

Bone Marrow Grafting for Leukemia and Lymphoma

Observational Leukemia Lymphoma Hematologic Diseases

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied
The protocol lists: collection and storage of tissue samples for research.
Who it may be relevant to
Registry conditions: Leukemia, Lymphoma, Hematologic Diseases. Basic parameters: 18 years — 70 years · All.
What needs checking
Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place
United States
Next step
Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →

Overview

The purpose of this study is to obtain tissue samples for ongoing studies regarding transplant outcomes and complications.

Detailed description

The purpose of this study is to acquire critical tissue and biological samples that can be evaluated to elucidate underlying mechanisms of disease control, transplant related complications and overall outcomes

Interventions

  • Procedure collection and storage of tissue samples for research
    Tissue samples include blood draws for the donor and recipient. A bone marrow sample may be obtained from the recipient. If the recipient undergoes a tissue biopsy for clinical reasons, a small fraction may be removed for research purposes. A small fraction of the donor graft may be removed at the time of collection for research.

Primary outcome measures

  • Identify and characterize proteins and genes that may contribute to the development and progression of cancer. [Time frame: blood sample is collected prior transplant, periodically during the first three months and then indefinately at follow up]

Eligibility criteria

Inclusion Criteria:- All hematopoietic cell transplant recipients and donors who agree to participate

Exclusion Criteria:- Subject does not agree to participate

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Healthy volunteers: No

Study design

Observational model
Cohort

Study locations

United States · 1 center
  • Stanford University School of Medicine — Stanford

Identifiers

NCT: NCT00186147 · IRB-08903 · P01CA049605

Primary sources (government registries)

View this study on ClinicalTrials.gov ↗